Chronic Unilateral Lumbar Radicular Pain

Sponsor
Ain Shams University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06092749
Collaborator
(none)
60
1
2
17.9
3.3

Study Details

Study Description

Brief Summary

Chronic neuropathic lumbar pain is among one of the most widespread complaints of patients.Many approaches have been attempted to target chronic pain, with varying efficacy and risks. Transgrade (TG) epidural injection is a new technique using a Racz- Coudé needle for epidural access at a "transgrade" angle without requiring any specialized hardware or accessories. Interlaminar (IL) epidural steroid injection (ESI) is one of the procedures that involves the delivery of injectate to the epidural space through directing a needle between the laminae of two adjacent vertebrae.

Condition or Disease Intervention/Treatment Phase
  • Other: Transgrade technique (TG)
  • Other: Interlaminar technique (IL)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Effectiveness of Transgrade vs Interlaminar Epidural Steroid Injection for Chronic Unilateral Lumbar Radicular Pain
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Apr 30, 2025
Anticipated Study Completion Date :
Apr 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Transgrade technique (TG)

Other: Transgrade technique (TG)
Transgrade (TG) Epidural Steroid Injection technique

Active Comparator: Interlaminar technique (IL)

Other: Interlaminar technique (IL)
Interlaminar (IL) Epidural Steroid Injection technique

Outcome Measures

Primary Outcome Measures

  1. The average numeric rating scale (NRS) pain scores [at 12 weeks after intervention]

    The numeric rating scale (NRS) is most commonly 0 to 10, with 0 being "no pain" and 10 being "the worst pain imaginable."

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • 6-month history of persistent pain in one leg with back pain.

  • Capable of giving informed consent.

  • Unsatisfactory response to conventional treatments including physical therapy or medications with a numeric rating scale (NRS) ≥ 5.

Exclusion Criteria:
  • Previous lumbar spinal surgery.

  • Myelopathy.

  • Rheumatoid disorders.

  • Psychiatric disorders

  • Bleeding or coagulation disorders

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ain-Shams University Hospitals Cairo Egypt

Sponsors and Collaborators

  • Ain Shams University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ibrahim Mamdouh Esmat, Assistant Professor of Anesthesia, Intensive Care and Pain Management Department, Faculty of Medicine, Ain- shams University, Cairo, Egypt., Ain Shams University
ClinicalTrials.gov Identifier:
NCT06092749
Other Study ID Numbers:
  • FMASU MD 286/ 2023
First Posted:
Oct 23, 2023
Last Update Posted:
Oct 23, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2023